Abstract: Disclosed are a method of manufacturing an electrode for a rechargeable lithium battery, and an electrode manufactured therefrom, and a rechargeable lithium battery including the electrode, the method of manufacturing an electrode for a rechargeable lithium battery including mixing together an electrode active material and a first ionic polymer to prepare a first slurry; mixing together the first slurry and a second ionic polymer to prepare a second slurry; mixing together the second slurry and a water-soluble binder to prepare an electrode active material layer slurry; coating the electrode active material layer slurry on a current collector, drying and compressing the electrode active material layer slurry to manufacture an electrode for a rechargeable lithium battery, wherein an amount of the first ionic polymer is about 20 to about 90 wt % based on a total amount of 100 wt % of the first ionic polymer and the second ionic polymer.

Abstract: Provided a liquid crystal composition including ceramide, a method of preparing the same, and a cosmetic composition including the same. According to a liquid crystal composition including various types of ceramide of an aspect and a method of preparing the same, the liquid crystal composition not only has high liquid crystal stability that liquid crystal is maintained even after 4 weeks at a high temperature, but also activities of increasing an amount of ceramide, increasing an expression level of aquaporin 3, increasing an amount of filaggrin, increasing an expression level of hyaluronic acid, increasing an expression level of loricrin, increasing an expression level of involucrin, and increasing a thickness of the skin, resulting in effects usefully available for amelioration of the skin conditions.

Abstract: A method of manufacturing an electrode for a rechargeable lithium battery, an electrode manufactured therefrom, and a rechargeable lithium battery including the electrode are provided. The method includes preparing an electrode active material layer slurry including an electrode active material and a polymer binder, coating the electrode active material layer slurry on a current collector and drying it while applying an electric field to form an active material layer, wherein the polymer binder includes a water-soluble binder and an ionic polymer.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating tuberculosis, comprising: (a) a pharmaceutically effective amount of a compound represented by the following chemical formula 1; and (b) a pharmaceutically acceptable carrier. Chemical formula 1 The compound contained as an active ingredient of the present invention inhibits the expression and activity of CO-DH in tubercle bacillus so as to effectively block the detoxification of carbon monoxide, which is an important survival factor of tubercle bacillus, and is safe for the human body since the compound targets CO-DH which does not exist in the human body. In addition, the compound creates a synergistic effect when combined with a conventional tuberculostatic drug, and thus can be more effective for treating tuberculosis.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating tuberculosis, comprising: (a) a pharmaceutically effective amount of a compound represented by the following chemical formula 1; and (b) a pharmaceutically acceptable carrier. Chemical formula 1 The compound contained as an active ingredient of the present invention inhibits the expression and activity of CO-DH in tubercle bacillus so as to effectively block the detoxification of carbon monoxide, which is an important survival factor of tubercle bacillus, and is safe for the human body since the compound targets CO-DH which does not exist in the human body. In addition, the compound creates a synergistic effect when combined with a conventional tuberculostatic drug, and thus can be more effective for treating tuberculosis.